相关实验视频
Updated: Sep 12, 2025

08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
6.5K
产后抗生素暴露时间对新生儿败血症的影响:一项前性队列研究
Rishi Sharma1, Sourabh Dutta2, Vanita Suri3
1Division of Neonatology, Department of Pediatrics, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India.
Indian pediatrics
|August 6, 2025
概括
产后抗生素暴露 (IAE) 的持续时间与培养负早期新生儿败血症 (EONS) 或晚期新生儿败血症 (LONS) 的更高风险无关. 需要进一步的研究来了解影响新生儿败血症结果的复杂因素.
科学领域:
- 新生儿医学 新生儿医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 在产前新生儿中,产内抗生素暴露 (IAE) 是常见的.
- IAE持续时间对新生儿败血症的影响尚不清楚.
- 早发性新生儿败血症 (EONS) 和晚发性新生儿败血症 (LONS) 是早产婴儿的重大问题.
研究的目的:
- 调查产后抗生素暴露 (IAE) 持续时间与培养负早期新生儿败血症 (EONS) 和生命第一周内任何晚期新生儿败血症 (LONS) 的风险之间的关联.
- 为了确定长时间的IAE是否会增加特定新生儿败血症类型的发病率.
主要方法:
- 一项涉及早产新生儿 (≤34周) 的队列研究,按IAE持续时间分类:没有IAE,<24小时IAE和≥24小时IAE.
- 培养负的EONS是主要结果,次要结果包括培养阳性败血症和多药耐药性败血症.
- 进行了单变量和多变量分析,以确定风险因素和IAE截止值.
主要成果:
- 培养阴性EONS的发生率随着IAE持续时间的延长而增加 (9.57%至36.90%,P<0.001).
- 培养积极的LONS发生率下降,而培养负的LONS比例随着更长的IAE而增加.
- 经过调整后的分析显示,IAE持续时间和培养负的EONS或LONS之间没有独立的关联.
结论:
- 产后抗生素暴露的持续时间与培养负的EONS或任何LONS的发病率增加没有独立关联.
- 虽然观察到趋势,但调整后的分析表明,其他因素可能对新生儿败血症的发展有更大的影响.
相关概念视频
Urine Studies II: Urine Culture and Sensitivity Test
116
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
116
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K

